(NasdaqGM:FATE), SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on July 2, 2025 the Company granted (i) non-qualified stock options to one […]

(NASDAQ:ASNS), FREMONT, Calif, July 03, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,626,019 shares

(NASDAQ:TSHA), DALLAS, July 03, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 1, 2025, the Compensation Committee of Taysha's Board of Directors

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today

Actelis Networks Announces Closing of Private Placement Priced At-the-Market under Nasdaq Rules GlobeNewswire July 03, 2025 FREMONT, Calif, July 03, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the closing of its previously announced

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 DALLAS, July 03, 2025 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today

Howard Community College Names New Interim Associate Vice Presidents GlobeNewswire July 03, 2025 COLUMBIA, MD, July 03, 2025 (GLOBE NEWSWIRE) — Howard Community College President Daria J. Willis today announced Michael Popp as the interim associate vice president of facilities management and operations, and Michael Smelkinson as the interim associate vice president of athletics. “These

(NASDAQ:WOOF), NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) between January 14, 2021 and June 5, 2025, both dates inclusive (the “Class

ROSEN, LEADING INVESTOR COUNSEL, Encourages Petco Health and Wellness Company, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WOOF GlobeNewswire July 03, 2025 NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on

Miami, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – Introduction The global investment landscape is undergoing a historic shift, creating an urgent need for action. Amid inflationary pressures, geopolitical disruption, and conflicting signals from financial markets, individual investors are facing mounting uncertainty. In what financial analyst Martin Weiss terms the “Age of Chaos,” the